Purushotham Anand D
Cambridge Breast Unit, Addenbrooke's NHS Trust, Cambridge, UK.
Breast Cancer Res. 2003;5(6):309-12. doi: 10.1186/bcr649. Epub 2003 Oct 9.
The treatment of ductal carcinoma in situ (DCIS) involves adequate surgical excision with adjuvant radiotherapy where appropriate. An inadequate excision margin and young age are independent risk factors for local recurrence. Routine surgery to axillary lymph nodes is not recommended in pure DCIS. In localised DCIS, adjuvant radiotherapy is recommended on the basis of tumour size, margin width and pathological subtypes. The role of adjuvant tamoxifen as systemic therapy is controversial. The treatment of atypical ductal/lobular hyperplasia and lobular carcinoma in situ involves surgical excision to exclude coexisting DCIS or invasive disease.
导管原位癌(DCIS)的治疗包括在适当情况下进行充分的手术切除并辅以放疗。切缘不充分和年轻是局部复发的独立危险因素。对于单纯DCIS,不建议常规进行腋窝淋巴结手术。在局限性DCIS中,根据肿瘤大小、切缘宽度和病理亚型推荐辅助放疗。辅助他莫昔芬作为全身治疗的作用存在争议。非典型导管/小叶增生和小叶原位癌的治疗包括手术切除以排除并存的DCIS或浸润性疾病。